News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Michael Ong received $2.4M for metastatic prostate cancer – CCTG
Photo taken from CCTG/X
Aug 12, 2024, 01:27

Michael Ong received $2.4M for metastatic prostate cancer – CCTG

The Canadian Cancer Trials Group shared on X:

“Congratulations to Dr Michael Ong, who has received $2,487,015 over 7 years from CIHR to support the CCTG PR26 (TRIPLE-SWITCH) trial. The study aims to personalize chemotherapy use and improve survival for patients with metastatic prostate cancer.”

Read further.
Source: The Canadian Cancer Trials Group/X

cancer CCTG chemotherapy metastatic prostate cancer Michael Ong OncoDaily Oncology The Canadian Cancer Trials Group
Special Coverage
Science
Aug 21, 2025, 06:29
Moazzam Shahzad: The Impact of MRD Status after Matched Donor alloHCT in AML
Insight
Aug 21, 2025, 00:36
Tom Powles: IMVIGOR011 Trial Brings ctDNA-Guided Adjuvant Immunotherapy to Bladder Cancer
Voices
Aug 21, 2025, 00:00
Kristina Lindemann: Advancing Gynecological Cancer Trials with ENGOT in Norway
Voices
Aug 20, 2025, 23:11
Anne Susanty: Sharing the Stage with Guillermo Chantada at SIOP 2024
Career Updates
Aug 20, 2025, 22:08
Devon J Shedlock Named Vice President and Head of Oncology Cell Therapy Technology at Genentech
Voices
Aug 20, 2025, 21:51
Catharine Young: The Power Patient Advocacy
Voices
Aug 20, 2025, 21:35
Ashley Russo: Why I’m Shaving My Head
Voices
Aug 20, 2025, 21:04
Fumiko Ladd Chino: Practical Insights on Breast Cancer Recurrence Risk Calculator
Voices
Aug 20, 2025, 20:18
Registration Is Open for the UH/CWRU’s Radiation Oncology Residency Program's Open House
Voices
Aug 20, 2025, 19:53
Albert Koong: Advancing Pancreatic Cancer Understanding and Treatment at MD Anderson
Societies
Aug 20, 2025, 19:41
New Posttraumatic Growth Qualification Program Offered by Boulder Crest Foundation
Voices
Aug 20, 2025, 19:35
Paolo Tarantino on Investigating Dato-DXd in HER2- Breast Cancer Brain Metastases - VJ Oncology